C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular
John Gunstad1, Linda Bausserman, Robert H Paul
1Brown Medical School, Providence, Rhode Island, USA. jgunstad@kent.edu
Insights
In older adults with cardiovascular disease, C-reactive protein (CRP) is linked to cognitive decline, but homocysteine (HCY) is not. This suggests inflammation, not HCY, may impact cognition in this population.
Area of Science:
- Neurology
- Cardiology
- Gerontology
Background:
- Cardiovascular disease (CVD) is a known risk factor for cognitive impairment and dementia.
- Elevated homocysteine (HCY) and C-reactive protein (CRP) are implicated in cognitive dysfunction.
- The independent contribution of HCY and CRP to cognitive risk in CVD patients is not well understood.
Purpose of the Study:
- To investigate the association between HCY and CRP levels and cognitive performance in older adults with CVD.
Main Methods:
- 126 older patients with CVD underwent blood tests and neuropsychological evaluations.
- A subset (n=37) had neuroimaging to assess white matter disease.
- Statistical analyses adjusted for demographic and medical factors.
Main Results:
- No significant relationship was found between HCY and cognitive performance.
- CRP showed significant independent associations with global cognitive performance, attention, executive function, memory, and visuospatial abilities.
- Neither HCY nor CRP correlated with white matter disease extent or brain volume.
Conclusions:
- CRP, an inflammatory marker, is independently associated with cognitive function in older CVD patients.
- HCY levels do not appear to impact cognition in this cohort.
- Further research is needed to elucidate the mechanisms of inflammation's effect on cognition and potential therapeutic targets.
Abstract:
Cardiovascular disease (CVD) is a risk factor for cognitive impairment and dementia. Recent studies implicate homocysteine (HCY) and C-reactive protein (CRP) in this increased risk, as both are associated with cognitive dysfunction in demented and non-demented patients. However, it remains unclear whether they confer added risk in older adults with CVD. A total of 126 older CVD patients underwent blood and neuropsychological evaluation as part of a prospective examination of the neurocognitive consequences of CVD. A subset of these participants (n=37) also underwent neuroimaging to quantify the degree of white matter disease. After adjusting for demographic and medical factors, no significant relationship emerged between HCY and cognitive performance. In contrast, CRP showed significant independent relationships to test performance, including global cognitive performance, attention/psychomotor function, executive function, memory, and visuospatial abilities. Neither HCY nor CRP was related to extent of white matter disease or whole brain volume on magnetic resonance imaging. Further study is needed to identify mechanisms by which inflammatory processes impact on cognitive function and to determine whether reducing circulating levels of inflammatory markers results in improved cognition.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cognitive Development During Adulthood
